Authors

• Anna L. Meyer (ORCID: https://orcid.org/0000-0002-4833-8014)
• Kambiz Hassan (ORCID: https://orcid.org/0000-0002-5485-4461)
• Marijana Matejic-Spasic (ORCID: https://orcid.org/0009-0002-8346-8831)
• Steven Hunter
• H. Maechler
• Martin H. Bernardi (ORCID: https://orcid.org/0000-0002-8297-898X)
• Matthias Thielmann (ORCID: https://orcid.org/0000-0002-1007-2871)
• Robert F. Storey (ORCID: https://orcid.org/0000-0002-6677-6229)
• Michael Schmoeckel (ORCID: https://orcid.org/0009-0005-2399-2836)
• Thomas S. Eberle (ORCID: https://orcid.org/0000-0001-9769-7892)
• Efthymios Deliargyris (ORCID: https://orcid.org/0000-0002-1893-7024)
• Nándor Marczin
• Ulf Guenther (ORCID: https://orcid.org/0000-0003-4068-3849)
• D. Wendt (ORCID: https://orcid.org/0009-0008-1074-7200)
• Bernd Panholzer
• Nikolaas deNeve

Institutions

• Medical University of Graz (AT)
• Heidelberg University (DE)
• Northern General Hospital (GB)
• University Hospital Heidelberg (DE)
• Harefield Hospital (GB)
• Onze Lieve Vrouwziekenhuis Hospital (BE)
• Sheffield Teaching Hospitals NHS Foundation Trust (GB)
• Klinikum Oldenburg (DE)
• CytoSorbents (Germany) (DE)
• Essen University Hospital (DE)
• Asklepios Klinik St. Georg (DE)
• CytoSorbents (United States) (US)
• San Diego Cardiac Center (US)
• West German Heart and Vascular Center Essen (DE)
• Medical University of Vienna (AT)
• Ludwig-Maximilians-Universität München (DE)
• University of Sheffield (GB)

Publication Details

Journal

Cardiovascular revascularization medicine

Published

2025-02-28

DOI

https://doi.org/10.1016/j.carrev.2025.02.015

Citations

2

Primary Topic

Antiplatelet Therapy and Cardiovascular Diseases

Type

article

Field-Weighted Citation Impact

2.78